These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6133759

  • 1. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
    Smiseth OA.
    Eur J Pharmacol; 1983 Mar 04; 87(4):379-86. PubMed ID: 6133759
    [Abstract] [Full Text] [Related]

  • 2. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
    Shen YT, Cervoni P, Claus T, Vatner SF.
    J Pharmacol Exp Ther; 1996 Sep 04; 278(3):1435-43. PubMed ID: 8819531
    [Abstract] [Full Text] [Related]

  • 3. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R, Meyer J, Schweizer P, Lambertz H, Voelker W, Effert S.
    Acta Med Scand Suppl; 1982 Sep 04; 659():169-80. PubMed ID: 6127887
    [Abstract] [Full Text] [Related]

  • 4. A reproducible and stable model of acute ischaemic left ventricular failure in dogs.
    Smiseth OA, Mjøs OD.
    Clin Physiol; 1982 Jun 04; 2(3):225-39. PubMed ID: 6889941
    [Abstract] [Full Text] [Related]

  • 5. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI, Silke B, Barker MC, Saxton CA, Taylor SH.
    Eur Heart J; 1982 Jun 04; 3(3):238-45. PubMed ID: 6125392
    [No Abstract] [Full Text] [Related]

  • 6. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
    Colucci WS, Alexander RW, Williams GH, Rude RE, Holman BL, Konstam MA, Wynne J, Mudge GH, Braunwald E.
    N Engl J Med; 1981 Jul 23; 305(4):185-90. PubMed ID: 6113543
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
    Vik-Mo H, Yasay G, Maroko PR, Ribeiro LG.
    J Cardiovasc Pharmacol; 1985 Jul 23; 7(4):784-90. PubMed ID: 2410722
    [Abstract] [Full Text] [Related]

  • 8. Haemodynamic and metabolic consequences of elevated plasma free fatty acids during acute ischaemic left ventricular failure in dogs.
    Smiseth OA, Mjøs OD.
    Scand J Clin Lab Invest; 1985 Oct 23; 45(6):515-20. PubMed ID: 4070953
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR, Canepa-Anson R, Kuan P, Whitaker NH, Carnie J, Warnes C, Reuben SR, Poole-Wilson PA, Sutton GC.
    Br Med J (Clin Res Ed); 1981 May 02; 282(6274):1423-6. PubMed ID: 6112039
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of the converting enzyme inhibitor ramipril (HOE 498) in anesthetized dogs with acute ischemic left ventricular failure.
    Schölkens BA, Martorana PA, Göbel H, Gehring D.
    Clin Exp Hypertens A; 1986 May 02; 8(6):1033-48. PubMed ID: 3019594
    [Abstract] [Full Text] [Related]

  • 13. Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs.
    Vatner SF, Knight DR, Hintze TH.
    Am J Physiol; 1985 Jul 02; 249(1 Pt 2):H49-56. PubMed ID: 2861749
    [Abstract] [Full Text] [Related]

  • 14. Intravenous pirbuterol.
    Leier CV, Nelson S, Huss P, Bianchine JR, Olukotun AY, Taylor CR, Salzburg DS.
    Clin Pharmacol Ther; 1982 Jan 02; 31(1):89-94. PubMed ID: 7053311
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of cardiac denervation on development of heart failure and catecholamine desensitization.
    Sato N, Vatner SF, Shen YT, Kudej RK, Ghaleh-Marzban B, Uechi M, Asai K, Mirsky I, Patrick TA, Shannon RP, Vatner DE.
    Circulation; 1997 Apr 15; 95(8):2130-40. PubMed ID: 9133524
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE, Turi Z, Brown EJ, Lorell BH, Colucci WS, Mudge GH, Taylor CR, Grossman W.
    Circulation; 1981 Jul 15; 64(1):139-45. PubMed ID: 7237712
    [Abstract] [Full Text] [Related]

  • 18. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA, Tabrizchi R.
    Br J Pharmacol; 1998 Oct 15; 125(4):651-8. PubMed ID: 9831898
    [Abstract] [Full Text] [Related]

  • 19. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
    Timmis AD, Bergman G, Walker L, Monaghan MJ, Jewitt DE.
    Int J Cardiol; 1984 Mar 15; 5(3):327-38. PubMed ID: 6706438
    [Abstract] [Full Text] [Related]

  • 20. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W, Prince K, Whyte K, MacNee W, Flenley DC.
    Am Rev Respir Dis; 1989 Feb 15; 139(2):492-7. PubMed ID: 2563321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.